GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales
1. GDRX reported Q4 revenue of $198.6 million, missing estimates slightly. 2. Fiscal year sales totaled $792.3 million, below expected guidance. 3. Q4 adjusted EPS was 9 cents, missing the consensus of 10 cents. 4. Subscription revenue decreased by 8%, driven by ending Kroger Savings Club. 5. 2025 revenue outlook is $810 million to $840 million, potential growth forecast.